• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普罗帕酮对近期发生的持续性房颤进行药物复律

[Pharmacologic cardioversion with propafenone of stable atrial fibrillation of recent onset].

作者信息

Capucci A, Gubelli S, Carini G, Frabetti L, Magnani B

机构信息

Istituto di Malattie dell'Apparato Cardiovascolare, Università degli Studi di Bologna.

出版信息

G Ital Cardiol. 1987 Nov;17(11):975-82.

PMID:3446571
Abstract

The efficacy of intravenous propafenone (P) infused at 2 mg/kg in 3 min as a loading dose followed by 0.007 mg/kg/min along 24 hours, in converting atrial fibrillation (AF) was evaluated under continuous electrocardiographic and blood pressure control in 22 patients. In case of inefficacy after a wash out of 24 hours, amiodarone (A) 5 mg/kg in 3 min followed by 1.8 gr/24 hours was infused. AF had to be constant (at least one 24/hour Holter recording) and of recent onset. All the patients were NYHA class 1 or 2. Ten patients reverted to sinus rhythm after P usually within 60 min; two of the non responders reverted after A and ten did not revert at all. RR intervals were significantly shorter in the responders compared to the others: mean value 537 +/- 64 vs 771 +/- 200 msec (p less than 0.001). During P the QRS duration increased 12.9% (p less than 0.005) and QTc of a lesser extent 7.8%; during A QRS did not modify significantly and QTc prolonged 9.5% (p less than 0.002). Propafenone i.v. infusion appears to be a rapid effective method of converting recent onset AF to sinus rhythm in patients with high ventricular rate. Amiodarone i.v. does not significantly help in converting to sinus rhythm the patients non responder to P.

摘要

在持续心电图和血压监测下,对22例患者评估了静脉注射普罗帕酮(P)的疗效。负荷剂量为在3分钟内静脉注射2mg/kg,随后以0.007mg/kg/min的速度持续输注24小时,观察其对房颤(AF)的转复效果。若24小时洗脱期后无效,则静脉注射胺碘酮(A),负荷剂量为5mg/kg,3分钟内注射完毕,随后以1.8g/24小时的速度持续输注。房颤必须持续存在(至少有一次24小时动态心电图记录)且为近期发作。所有患者的心功能分级均为纽约心脏病协会(NYHA)1级或2级。10例患者在使用P后通常在60分钟内恢复窦性心律;2例对P无反应的患者在使用A后恢复窦性心律,另外10例患者则根本未恢复。与未恢复者相比,恢复者的RR间期明显缩短:平均值分别为537±64毫秒和771±200毫秒(p<0.001)。使用P期间,QRS时限增加了12.9%(p<0.005),QTc增加幅度较小,为7.8%;使用A期间,QRS时限无明显改变,QTc延长了9.5%(p<0.002)。静脉输注普罗帕酮似乎是将近期发作的房颤且心室率较高的患者快速有效地转复为窦性心律的方法。静脉注射胺碘酮对P治疗无效的患者转复为窦性心律并无明显帮助。

相似文献

1
[Pharmacologic cardioversion with propafenone of stable atrial fibrillation of recent onset].普罗帕酮对近期发生的持续性房颤进行药物复律
G Ital Cardiol. 1987 Nov;17(11):975-82.
2
[Fibrillation and atrial flutter. Immediate control and conversion to sinus rhythm with intravenous propafenone].[心房颤动与心房扑动。静脉注射普罗帕酮即刻控制并转复为窦性心律]
G Ital Cardiol. 1987 Aug;17(8):653-60.
3
[A comparison between propafenone and amiodarone in the conversion to sinus rhythm of atrial fibrillation of recent onset].普罗帕酮与胺碘酮在近期发作的心房颤动转复为窦性心律中的比较
Minerva Cardioangiol. 1994 Jun;42(6):293-7.
4
[Efficacy of intravenous and per os propafenone in the ambulatory treatment of recent-onset atrial fibrillation].静脉注射与口服普罗帕酮在近期发作心房颤动门诊治疗中的疗效
G Ital Cardiol. 1992 Mar;22(3):257-65.
5
A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.普鲁卡因胺、普罗帕酮与胺碘酮转复近期发作房颤的疗效及安全性比较研究
Am J Cardiol. 2007 Jun 15;99(12):1721-5. doi: 10.1016/j.amjcard.2007.01.059. Epub 2007 Apr 26.
6
Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.口服普罗帕酮与奎尼丁治疗近期发作心房颤动的疗效和耐受性:一项随机、前瞻性研究。
Cardiol J. 2009;16(6):521-7.
7
Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.伊布利特用于接受胺碘酮或普罗帕酮治疗的心房扑动和心房颤动患者复律的有效性和安全性。
Pacing Clin Electrophysiol. 2005 Sep;28(9):954-61. doi: 10.1111/j.1540-8159.2005.00212.x.
8
Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial.急诊室中普罗帕酮静脉注射与口服首剂负荷量用于近期发作房颤转复的随机试验
Ital Heart J. 2000 Jul;1(7):475-9.
9
Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.静脉注射伊布利特与普罗帕酮用于快速终止近期发作房颤的比较。
Int J Clin Pract. 2005 Dec;59(12):1395-400. doi: 10.1111/j.1368-5031.2005.00705.x.
10
[Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].伊布利特与普罗帕酮对持续时间少于90天的心房颤动和心房扑动进行即刻复律:一项多中心研究
Zhonghua Yi Xue Za Zhi. 2005 Mar 30;85(12):798-801.

引用本文的文献

1
Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.
Cardiovasc Drugs Ther. 1996 May;10(2):153-7. doi: 10.1007/BF00823593.
2
Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.普罗帕酮治疗心律失常。风险效益评估。
Drug Saf. 1995 Jan;12(1):55-72. doi: 10.2165/00002018-199512010-00005.
3
Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.普罗帕酮。对其药理学、药代动力学及在心律失常治疗中的应用的重新评估。
Drugs. 1993 Jan;45(1):85-130. doi: 10.2165/00003495-199345010-00008.